Will Personalized Medicine Mean Higher Costs for Consumers?
Harvard Business Review
MARCH 1, 2018
Consequently, if we want new medical innovations to be financially viable for the patients who need it most, health insurance markets need to be regulated to eliminate the perverse financial incentives that limit patients’ coverage. Insurance markets are failing to deliver. First, a little background. Insight Center.
Let's personalize your content